000 | 01949 a2200505 4500 | ||
---|---|---|---|
005 | 20250514214736.0 | ||
264 | 0 | _c20050310 | |
008 | 200503s 0 0 eng d | ||
022 | _a0360-3016 | ||
024 | 7 |
_a10.1016/j.ijrobp.2004.06.258 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRao, Ravi D | |
245 | 0 | 0 |
_aPhase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): results of North Central Cancer Treatment Group trial 98-72-51. _h[electronic resource] |
260 |
_bInternational journal of radiation oncology, biology, physics _cFeb 2005 |
||
300 |
_a380-6 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 |
_aAstrocytoma _xdrug therapy |
650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCarmustine _xadministration & dosage |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRadiotherapy Dosage |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aKrishnan, Sunil | |
700 | 1 | _aFitch, Tom R | |
700 | 1 | _aSchomberg, Paula J | |
700 | 1 | _aDinapoli, Robert P | |
700 | 1 | _aNordstrom, Kathleen | |
700 | 1 | _aScheithauer, Bernd | |
700 | 1 | _aO'Fallon, Judith R | |
700 | 1 | _aMaurer, Matthew J | |
700 | 1 | _aBuckner, Jan C | |
773 | 0 |
_tInternational journal of radiation oncology, biology, physics _gvol. 61 _gno. 2 _gp. 380-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijrobp.2004.06.258 _zAvailable from publisher's website |
999 |
_c15346441 _d15346441 |